Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 1196 | 1.570 |
Why?
|
| Immunotherapy, Adoptive | 10 | 2025 | 804 | 1.280 |
Why?
|
| T-Lymphocytes | 9 | 2024 | 1677 | 1.180 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2023 | 477 | 1.040 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2023 | 285 | 0.990 |
Why?
|
| Gangliosides | 1 | 2024 | 64 | 0.880 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2024 | 194 | 0.770 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2023 | 157 | 0.760 |
Why?
|
| Virus Diseases | 1 | 2023 | 280 | 0.680 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 52 | 0.650 |
Why?
|
| Adoptive Transfer | 1 | 2019 | 237 | 0.610 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 268 | 0.600 |
Why?
|
| Transplant Recipients | 1 | 2019 | 209 | 0.580 |
Why?
|
| DNA Virus Infections | 1 | 2017 | 22 | 0.580 |
Why?
|
| DNA Viruses | 1 | 2017 | 33 | 0.570 |
Why?
|
| CD3 Complex | 1 | 2017 | 83 | 0.560 |
Why?
|
| CD28 Antigens | 1 | 2017 | 78 | 0.560 |
Why?
|
| Tissue Donors | 1 | 2019 | 496 | 0.520 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 193 | 0.520 |
Why?
|
| Herpesvirus 4, Human | 5 | 2023 | 659 | 0.520 |
Why?
|
| Transplantation Conditioning | 5 | 2023 | 323 | 0.490 |
Why?
|
| Graft vs Host Disease | 3 | 2023 | 542 | 0.450 |
Why?
|
| Neoplasms | 3 | 2025 | 2766 | 0.440 |
Why?
|
| Transplantation, Homologous | 5 | 2023 | 657 | 0.390 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 151 | 0.360 |
Why?
|
| Lymphoma | 2 | 2024 | 322 | 0.360 |
Why?
|
| Hematologic Neoplasms | 2 | 2025 | 287 | 0.350 |
Why?
|
| Interleukin-7 | 3 | 2023 | 43 | 0.340 |
Why?
|
| Leukemia | 2 | 2024 | 376 | 0.340 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 293 | 0.330 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2021 | 532 | 0.300 |
Why?
|
| Child | 15 | 2025 | 24221 | 0.270 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 804 | 0.260 |
Why?
|
| Child, Preschool | 11 | 2025 | 13878 | 0.250 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1230 | 0.250 |
Why?
|
| Alemtuzumab | 3 | 2023 | 88 | 0.250 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2019 | 263 | 0.240 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 21 | 0.230 |
Why?
|
| Neuroblastoma | 3 | 2019 | 509 | 0.230 |
Why?
|
| beta-Thalassemia | 1 | 2023 | 28 | 0.220 |
Why?
|
| Adolescent | 13 | 2025 | 19093 | 0.220 |
Why?
|
| Neoplasm Grading | 1 | 2024 | 267 | 0.220 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 47 | 0.210 |
Why?
|
| Humans | 26 | 2025 | 123146 | 0.200 |
Why?
|
| CD27 Ligand | 1 | 2021 | 5 | 0.190 |
Why?
|
| Adult | 12 | 2024 | 29029 | 0.190 |
Why?
|
| Young Adult | 6 | 2024 | 8864 | 0.190 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 41 | 0.190 |
Why?
|
| Infant | 6 | 2025 | 12339 | 0.180 |
Why?
|
| Tissue Banks | 1 | 2019 | 26 | 0.170 |
Why?
|
| Glioma | 1 | 2024 | 491 | 0.170 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 48 | 0.150 |
Why?
|
| Antigens, CD19 | 1 | 2019 | 178 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2019 | 243 | 0.150 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 135 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5046 | 0.150 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2019 | 162 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 22 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2019 | 769 | 0.150 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2018 | 65 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2023 | 744 | 0.140 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 334 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 217 | 0.140 |
Why?
|
| Adenoviruses, Human | 1 | 2017 | 80 | 0.140 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 69 | 0.140 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 90 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2022 | 656 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 669 | 0.140 |
Why?
|
| Herpesvirus 6, Human | 1 | 2017 | 58 | 0.140 |
Why?
|
| BK Virus | 1 | 2017 | 59 | 0.140 |
Why?
|
| Male | 11 | 2025 | 60034 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 322 | 0.140 |
Why?
|
| Female | 12 | 2025 | 65443 | 0.130 |
Why?
|
| Interleukin-15 | 1 | 2017 | 93 | 0.130 |
Why?
|
| Interleukin-2 | 1 | 2017 | 230 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2017 | 330 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 250 | 0.130 |
Why?
|
| Mice | 6 | 2023 | 17486 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 197 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 677 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 803 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 876 | 0.120 |
Why?
|
| Cerebroside-Sulfatase | 1 | 1994 | 6 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 501 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2017 | 333 | 0.110 |
Why?
|
| Leukocytes | 1 | 1994 | 207 | 0.100 |
Why?
|
| Retrospective Studies | 8 | 2025 | 16000 | 0.100 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 534 | 0.100 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 185 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12116 | 0.100 |
Why?
|
| Animals | 6 | 2023 | 33718 | 0.090 |
Why?
|
| Age of Onset | 1 | 2012 | 581 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3277 | 0.090 |
Why?
|
| Unrelated Donors | 2 | 2021 | 82 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1907 | 0.080 |
Why?
|
| Aged | 6 | 2024 | 19068 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 327 | 0.080 |
Why?
|
| Recurrence | 2 | 2022 | 1422 | 0.070 |
Why?
|
| Middle Aged | 6 | 2024 | 25964 | 0.070 |
Why?
|
| Cytokines | 2 | 2023 | 1283 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2024 | 123 | 0.060 |
Why?
|
| Busulfan | 1 | 2023 | 44 | 0.050 |
Why?
|
| Risk Factors | 2 | 2017 | 10011 | 0.050 |
Why?
|
| Neutropenia | 1 | 2024 | 202 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 228 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 21 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 420 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2307 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 194 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 20 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 95 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 740 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 137 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 397 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2001 | 335 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 40 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 58 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 533 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 58 | 0.040 |
Why?
|
| Allografts | 1 | 2017 | 190 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 98 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2018 | 272 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 173 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2019 | 605 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 233 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2019 | 935 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 860 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4505 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 390 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 402 | 0.030 |
Why?
|
| Texas | 1 | 2021 | 3545 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 1993 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 1861 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 1569 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6027 | 0.030 |
Why?
|
| Lysosomes | 1 | 1994 | 232 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 950 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3050 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1870 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4268 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1994 | 1432 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6372 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 4494 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8104 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2001 | 247 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 425 | 0.010 |
Why?
|
| Monocytes | 1 | 2001 | 346 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 518 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 2023 | 0.010 |
Why?
|